Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.39 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.39 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | GRM6 | O15303 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL347774 | 0.84 | CYP3A4 (0.40) | MEN1KMT2ATDP1LMNATHRB | |
| SCHEMBL8565728 | 0.84 | ADRA1A (0.39) | MEN1KMT2ATDP1LMNAALDH1A1 | |
| SCHEMBL20797216 | 0.83 | PDK1 (0.37) | MEN1KMT2ATDP1LMNATHRB | |
| SCHEMBL27880238 | 0.83 | RAB9A (0.37) | MEN1KMT2ATDP1LMNATHRB | |
| SCHEMBL2947290 | 0.83 | ERN1 (0.39) | MEN1KMT2ATDP1LMNATHRB | |
| SCHEMBL1935692 | 0.83 | PIM1 (0.39) | MEN1KMT2AALDH1A1ADRA1AADRA1B | |
| SCHEMBL109178 | 0.82 | TSHR (0.50) | MEN1KMT2ATDP1LMNAALDH1A1 | |
| SCHEMBL30111657 | 0.82 | TSHR (0.50) | MEN1KMT2ATDP1LMNAALDH1A1 | |
| SCHEMBL6874838 | 0.81 | ATR (0.36) | MEN1KMT2AALDH1A1ADRA1AADRA1B | |
| Hydrogen Peroxide SCHEMBL29048859 | 0.81 | TSHR (0.48) | MEN1KMT2ATDP1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114539280-B | Novel compounds and structures for detecting hydrogen sulfide | 佳能株式会社 | 2024-07-30 | — | — | CN | disclosed |
| US-12049469-B2 | Compound and structural body for detecting hydrogen sulfide | CANON KABUSHIKI KAISHA (JP) | 2024-07-30 | — | — | US | disclosed |
| CN-114539280-A | Novel compound and structure for detecting hydrogen sulfide | 佳能株式会社 | 2022-05-27 | — | — | CN | disclosed |
| US-20220162226-A1 | NOVEL COMPOUND AND STRUCTURAL BODY FOR DETECTING HYDROGEN SULFIDE | CANON KABUSHIKI KAISHA (JP) | 2022-05-26 | — | — | US | disclosed |
| US-20220162226-A1 | NOVEL COMPOUND AND STRUCTURAL BODY FOR DETECTING HYDROGEN SULFIDE | CANON KABUSHIKI KAISHA (JP) | 2022-05-26 | — | — | US | disclosed |
| US-10421853-B2 | Photosensitive gas generating agent and photocurable composition | CANON KABUSHIKI KAISHA (JP) | 2019-09-24 | — | — | US | disclosed |
| CN-105008350-B | Antiviral compound | 弗·哈夫曼-拉罗切有限公司 | 2018-05-08 | — | — | CN | disclosed |
| CN-105009256-B | Photonasty gas producing agent and Photocurable composition | 佳能株式会社 | 2017-09-15 | — | — | CN | disclosed |
| EP-2941781-B1 | PHOTOSENSITIVE GAS GENERATING AGENT AND PHOTOCURABLE COMPOSITION | CANON KK (JP) | 2017-08-09 | — | — | EP | disclosed |
| US-20150368433-A1 | PHOTOSENSITIVE GAS GENERATING AGENT AND PHOTOCURABLE COMPOSITION | CANON KABUSHIKI KAISHA (JP) | 2015-12-24 | — | — | US | disclosed |
| EP-0530579-A1 | Condensed pyrimidine derivatives antitumor agents | Eisai Co., Ltd. (JP) | 1993-03-10 | — | — | EP | disclosed |
| US-5155113-A | Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-10-13 | — | — | US | disclosed |
| EP-0180188-B1 | A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-04-15 | — | — | EP | disclosed |
| EP-0180897-B1 | 5-FLUOROURACIL DERIVATIVES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-08-07 | — | — | EP | disclosed |
| EP-0436902-A1 | 5-Fluorouracil derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-07-17 | — | — | EP | disclosed |
| US-4983609-A | Anticancer agents | OTSUKA PHARMACEUTICAL (JP) | 1991-01-08 | — | — | US | disclosed |
| US-4864021-A | ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-09-05 | — | — | US | disclosed |
| EP-0323441-A2 | 5-Fluorouracil derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-07-05 | — | — | EP | disclosed |
| EP-0180897-A2 | 5-Fluorouracil derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-05-14 | — | — | EP | disclosed |
| EP-0180188-A2 | A composition for increasing the anti-cancer activity of an anti-cancer compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-05-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162226-A1 | NOVEL COMPOUND AND STRUCTURAL BODY FOR DETECTING HYDROGEN SULFIDE | SQOR, CBS, XDH | MEN1 2223/4885KMT2A 3731/4885TDP1 4708/4885 |
| US-20150368433-A1 | PHOTOSENSITIVE GAS GENERATING AGENT AND PHOTOCURABLE COMPOSITION | PFN1, PFAS, FRG1 | MEN1 1716/4885KMT2A 2544/4885TDP1 4003/4885 |
| US-10421853-B2 | Photosensitive gas generating agent and photocurable composition | PFN1, PFAS, FRG1 | MEN1 1716/4885KMT2A 2544/4885TDP1 4003/4885 |
| US-12049469-B2 | Compound and structural body for detecting hydrogen sulfide | SQOR, XDH, TST | MEN1 1839/4885KMT2A 3494/4885TDP1 4583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.